BioNTech SE Investor

At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized.


Invests into

Industry: Genomic and Epigenominc Instabillity
Headquarters: Mainz, Rheinland-Pfalz, Germany